Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind Randomized Controlled Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Allogenic Umbilical Cord Blood and Erythropoietin for Children With Cerebral Palsy

NCT01193660 is registered in ClinicalTrials.gov with Sung Kwang Medical Foundation as lead sponsor.

NCT NCT01193660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01193660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind Randomized Controlled Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Allogenic Umbilical Cord Blood and Erythropoietin for Children With Cerebral Palsy
Lead sponsor
Sung Kwang Medical Foundation
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2010
Completion date
April 30, 2011
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy